Explore Company News Direct From Our Network
Global News from Our Network.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 1,416
- Total Pages: 177
UCB licenses Antengene’s ATG-201 for autoimmune diseases
HONG KONG and BRUSSELS - Antengene Corporation Limited and UCB announced today they have entered into a worldwide exclusive licensing agreement for ATG-201, a CD19/CD3 bispecific T-cell engager antibody targeting B cell-related autoimmune diseases, according to a press release statement. Under the agreement, UCB receives worldwide exclusive rights to develop, manufacture and commercialize ATG-201. Antengene will receive $80 million in upfront and near-term milestone payments, comprising an initial $60 million upfront payment and an additional $20 million upon…
Read more on this story »
Partner Profile
Secarna Pharmaceuticals and Curie.Bio Expand Existing Partnership
Martinsried (Munich), Germany, March 3, 2026 - Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics today announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio announced in May 2025. The expansion includes Secarna’s support in identifying oligonucleotide candidates using its proprietary OligoCreator® platform for research and development projects conducted by Curie.Bio portfolio companies.
View original story »
Partner Profile
Peli BioThermal Announces Strategic Partnership with Polar Group in Brazil
MAPLE GROVE, Minn., March 2, 2026 /PRNewswire/ -- Peli BioThermal, a global provider of temperature-controlled packaging solutions for the life sciences industry, today announced a strategic partnership with Polar Group to expand the availability of its reusable and single-use cold chain solutions across Brazil.
View original story »
Partner Profile
Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing
The Woodlands, Texas— February 24, 2026/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Soter Bio, a CDMO specializing in RNA and RNA–lipid nanoparticle (LNP) manufacturing for research and GMP applications. Together, the companies will support integrated manufacturing pathways for complex cell therapy programs requiring coordinated biomolecule and cellular processing.
View original story »
Partner Profile
NorthX Biologics and Demeetra Announce Strategic Collaboration
NorthX Biologics and Demeetra today announced a strategic collaboration that combines a best-in-class, high-titer GS (−/−) CHO cell line with full freedom to operate—without additional IP-related costs. Together, the companies now offer an integrated solution spanning advanced cell line development (CLD), master cell banking (MCB), and GMP manufacturing services. The collaboration is designed to help biotech companies reach IND-enabling and clinical milestones faster by strengthening the parts of development that most often drive timelines and risk. By streamlining the path…
Read more on this story »
Partner Profile
Brainlab, Precision NeuroMed Partner on AI-Enabled Drug Delivery to Brain
Brainlab and Precision NeuroMed have a new strategic partnership for an artificial intelligence (AI)-enabled treatment planning platform. Once developed and commercialized, this platform will facilitate convection enhanced delivery (CED) to the brain. There are long-standing limitations in this area of medicine, the companies say, due to the…
Read more on this story »
Partner Profile
Astellas and Vir Biotechnology Announce Global Strategic Collaboration
Vir Biotechnology will receive $335M in upfront and near-term milestone payments, will split U.S. profit/loss equally with Astellas (50/50), and is eligible to receive up to an additional $1.37B in development, regulatory and sales milestones, along with tiered, double-digit royalties on ex-U.S. net sales -
View original story »
Partner Profile
Antengene Announces Clinical Collaboration with Junshi Biosciences
Shanghai and Hong Kong, PRC, February 25, 2026 — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, announced that it has entered into a clinical collaboration agreement with Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, SEHK: 1877.HK;…
Read more on this story »
Partner Profile
- Total Results: 1,416
- Total Pages: 177
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
